TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 2 | 3 | 3 | 1 | -7 | -5 | -19 | -4 |
| P | %wins | 50 | 100 | 100 | 0 | 0 | 0 | 42 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/20/12 13:56 | 12/19/12 | LPTN | Lpath, Inc | NV | Health | BioPrd | Biological Products, (No Diag | Mathews Charles | CA | D | P | 25 | 4.98 | 0 | 5 | 175 | 8 | D | -5 | -24 | -13 | -3 | -24 | -19 | -17 | 3 | -1 | 3 | 1 | -7 | -5 | -19 | |
3/7/12 09:01 | 3/6/12 | AVNR | Avanir Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mathews Charles | CA | D | P | 13 | 2.69 | 4 | 5 | 2 | 277 | I | 31 | -23 | -1 | 11 | -6 | -11 | -8 | -5 | 7 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |